Tirzepatide — 20mg
Product Overview
Tirzepatide is a synthetic peptide agonist with activity at both the GIP and GLP-1 receptors. It was engineered from a GIP-based sequence and includes structural modifications that support extended exposure.
Research Background
Laboratory studies indicate that tirzepatide does not engage its two receptors identically. Research has examined its relative receptor potency, cyclic-AMP signalling, beta-arrestin recruitment and receptor internalization, providing a useful model for biased and imbalanced dual-receptor agonism.
Current Areas of Investigation
Research applications include comparative receptor assays, pancreatic-cell signalling, metabolic-pathway models and studies comparing single- and multi-receptor incretin ligands.
In Plain Language
Researchers use tirzepatide to study how two nutrient-responsive hormone pathways work together in areas such as appetite cues, blood-sugar regulation and the biological response to food. GIP and GLP-1 receptors overlap in some functions but differ in receptor strength, signalling bias and tissue distribution.
In plain terms, the research asks how a combined signal may affect hunger, fullness, glucose-dependent insulin release and longer-term metabolic regulation. Studies have reported meaningful changes in glucose and body-weight measures, while mechanistic work continues to separate the contributions of GIP from GLP-1.
Product Specifications
- Catalogue No.: TR
- Vial Size: 20mg
Quality & Documentation
Lot-specific product documentation and Certificate of Analysis (COA) information may be available through AURAPEP where applicable.
Research Use Only
RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. Supplied strictly for laboratory, analytical and research purposes. Not intended for self-administration or to diagnose, treat, cure or prevent any disease.
